• xxx

PALLES, Dr Claire

Group Leader Gastrointestinal Cancer Genetics, Institute of Cancer and Genomic Sciences, University of Birmingham

My group aims to identify and characterise common and rare genetic variants associated with an increased risk of gastrointestinal cancers and their precursors.  We also investigate genetic variation that might predict high risk of adverse events following treatment with cancer therapeutics.  I am chief investigator of a clinical research study called The Immune Checkpoint Inhibitor Genetics study which collects samples and treatment side effect data from patients treated with immune checkpoint inhibitors and I am co-investigator of the CORGI 2 study which collects samples and data from patients with early onset colorectal cancer.

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.